Obstet Gynecol:癌症一年的治疗和护理需要多少钱?

2017-11-09 Heather_z727 来宝网

治疗癌症一年需要多少钱?这些很多癌症患者和照顾者们关心的话题。近期,发表于《妇产科》杂志上的一篇文章以卵巢癌为例进行了调查研究,女性卵巢癌患者接受手术和辅助化疗的平均医疗支出约10万美元,这是手术后的第一年。

卵巢癌手术后护理年花费约10万美元】治疗癌症一年需要多少钱?这些很多癌症患者和照顾者们关心的话题。近期,发表于《妇产科》杂志上的一篇文章以卵巢癌为例进行了调查研究,女性卵巢癌患者接受手术和辅助化疗的平均医疗支出约10万美元,这是手术后的第一年

卵巢癌是女性生殖器官常见的恶性肿瘤之一,发病率仅次于子宫颈癌和子宫体癌,而列居第三位,对妇女生命造成严重威胁。早期症状不明显。

来自哥伦比亚大学内科医生和外科医生们进行了一次回顾研究,他们将从2009年至2014年的女性卵巢癌患者数据进行总结,这些患者分别接受了手术治疗和化疗,研究人员希望知道从接受手术之后起的12个月之中,这些患者的医疗支出的总数究竟是多少?这些医疗费用包括,接受检查的费用在内。数据来自5031名女性卵巢癌患者。

研究人员发现,在接受治疗的第一年中,每个病人平均总医疗支出为93632美元。住院服务占支出的37.8%(30708美元),门诊服务的58.3%(52700美元),门诊药物成本为3.8%(1814美元)。现金支付中值为2998美元,其中包括1509美元门诊服务、589美元住院费用和351美元的门诊药物成本。

研究人员指出:“在术后第一年,女性卵巢癌的平均医疗成本大约是100000美元。在符合医疗保险的患者中,患者需要承担大约3%的费用,其他的则由国家来负担。”

原始出处:

Bercow Alexandra, Chen Ling, Chatterjee Sudeshna, et al. Cost of Care for the Initial Management of Ovarian Cancer. Obstetrics & Gynecology: Post Author Corrections: November 03, 2017, doi: 10.1097/AOG.0000000000002317.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044022, encodeId=29982044022f5, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Aug 15 00:33:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011352, encodeId=46fa2011352ad, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 21:33:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260775, encodeId=a1c6260e7544, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Sun Nov 12 11:25:08 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260260, encodeId=ad2f260260c8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Nov 10 10:52:51 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260069, encodeId=e76c260069f7, content=什么时候我们国家医疗能这样!加油!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/be4YlKNv3rT6se8HUMWmAyS3eywXjKkf3TaeJkKrgAdTM1l1WesYwgkw2VAOVEWicdb6rCiaRbttqjb9ozpjCkGQ/0, createdBy=2d322139779, createdName=欧阳星月dora, createdTime=Thu Nov 09 21:08:21 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2044022, encodeId=29982044022f5, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Aug 15 00:33:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011352, encodeId=46fa2011352ad, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 21:33:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260775, encodeId=a1c6260e7544, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Sun Nov 12 11:25:08 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260260, encodeId=ad2f260260c8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Nov 10 10:52:51 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260069, encodeId=e76c260069f7, content=什么时候我们国家医疗能这样!加油!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/be4YlKNv3rT6se8HUMWmAyS3eywXjKkf3TaeJkKrgAdTM1l1WesYwgkw2VAOVEWicdb6rCiaRbttqjb9ozpjCkGQ/0, createdBy=2d322139779, createdName=欧阳星月dora, createdTime=Thu Nov 09 21:08:21 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2018-08-06 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=2044022, encodeId=29982044022f5, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Aug 15 00:33:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011352, encodeId=46fa2011352ad, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 21:33:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260775, encodeId=a1c6260e7544, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Sun Nov 12 11:25:08 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260260, encodeId=ad2f260260c8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Nov 10 10:52:51 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260069, encodeId=e76c260069f7, content=什么时候我们国家医疗能这样!加油!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/be4YlKNv3rT6se8HUMWmAyS3eywXjKkf3TaeJkKrgAdTM1l1WesYwgkw2VAOVEWicdb6rCiaRbttqjb9ozpjCkGQ/0, createdBy=2d322139779, createdName=欧阳星月dora, createdTime=Thu Nov 09 21:08:21 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-12 天涯183

    非常好的文章.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2044022, encodeId=29982044022f5, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Aug 15 00:33:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011352, encodeId=46fa2011352ad, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 21:33:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260775, encodeId=a1c6260e7544, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Sun Nov 12 11:25:08 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260260, encodeId=ad2f260260c8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Nov 10 10:52:51 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260069, encodeId=e76c260069f7, content=什么时候我们国家医疗能这样!加油!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/be4YlKNv3rT6se8HUMWmAyS3eywXjKkf3TaeJkKrgAdTM1l1WesYwgkw2VAOVEWicdb6rCiaRbttqjb9ozpjCkGQ/0, createdBy=2d322139779, createdName=欧阳星月dora, createdTime=Thu Nov 09 21:08:21 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-10 明天会更好!

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2044022, encodeId=29982044022f5, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Wed Aug 15 00:33:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011352, encodeId=46fa2011352ad, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Aug 06 21:33:00 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260775, encodeId=a1c6260e7544, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Sun Nov 12 11:25:08 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260260, encodeId=ad2f260260c8, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Nov 10 10:52:51 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260069, encodeId=e76c260069f7, content=什么时候我们国家医疗能这样!加油!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/be4YlKNv3rT6se8HUMWmAyS3eywXjKkf3TaeJkKrgAdTM1l1WesYwgkw2VAOVEWicdb6rCiaRbttqjb9ozpjCkGQ/0, createdBy=2d322139779, createdName=欧阳星月dora, createdTime=Thu Nov 09 21:08:21 CST 2017, time=2017-11-09, status=1, ipAttribution=)]
    2017-11-09 欧阳星月dora

    什么时候我们国家医疗能这样!加油!!

    0

相关资讯

NAT COMMUN:霍普金斯医学院研究人员发现卵巢癌早期诊断方式

卵巢癌是妇科癌症死亡的主要原因,2 0年生存率低于30%,并且该情况在过去30年没有明显的改善。尽管研究人员做了大量的努力,但是各种筛查和治疗策略并没有导致整体生存率的提高。

Int J Nanomed:rGO-AgNPs联合TSA可更有效治疗卵巢癌

最近,纳米医学领域在疾病的预防、诊断和治疗方面是研究的热点。联合两种不同工作机制的分子进行联合治疗似乎是最有效的,可降低耐药性和不可忍受的副作用的发生的可能性。基于这一考虑,本研究旨在研究联合还原型石墨烯氧化物-银纳米粒子(rGO-AgNPs)和曲古抑菌素A(TSA)在人类卵巢癌细胞(SKOV3)中的治疗作用。使用称为番茄红素的生物分子合成rGO-AgNPs,并通过各种分析技术对其进行表征。使用各

肿瘤治疗电场为复发性卵巢癌患者带来新希望,无进展生存期延长两倍!

一项重磅2期临床试验致力于研究肿瘤治疗电场(下文简称为“TTFields”)在结合每周一次紫杉醇时对于复发性卵巢癌的疗效。美国癌症研究协会将亲自见证这一结果。

Onco Targets Ther:研究揭示NEAT1在卵巢癌中的表达及功能

研究已经证明富含核富集的转录物1(NEAT1)在许多癌症中起着肿瘤抑制剂的作用。然而,NEAT1在卵巢癌(OC)发展中的作用仍有待进一步明确。因此,本研究的目的是探讨NEAT1在OC中的表达和功能。通过定量实时聚合酶链式反应测定OC细胞系中NEAT1的表达水平。MTT法检测caspase-3活性,流式细胞术检测NEAT1、miR-34a-5p或B细胞淋巴瘤-2(BCL2)对OC细胞增殖和凋亡的影响

Elife:只需一管血,在早期阶段准确检测卵巢癌

因症状难以察觉,致死率高,卵巢癌一直被称为“沉默的杀手”。不过,美国的研究人员近日开发出一种新技术,可以在早期准确检测卵巢癌。他们通过鉴定血液中的循环microRNA网络来评估卵巢癌风险。这项成果在线发表于《eLife》上。

HE4检测助力远离卵巢癌

“近30年来卵巢癌患者的5年生存率没有明显提升,主要原因是早诊早查意识不够、规范化治疗和治疗方式选择不当。”近日,重庆市肿瘤医院妇科肿瘤中心首席专家、学科带头人周琦指出,卵巢癌可防可治,而治愈的关键就在于“早”。